Tag: precision oncology

MMF and rituximab combination effective in nephrotic syndrome

Optimizing Subtyping-Based Therapy in Triple-Negative Breast Cancer

byDaniel Goldshteinand1 others

January 15, 2024

1. The median progression-free survival was improved with the pooled subtyping-based therapy group compared to the control group (11.3 months ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Pfizer’s Talzenna combo significantly delays prostate cancer progression
Bottom-vented bottles may not reduce gastrointestinal discomfort in infants
Ketorolac administration after cesarean delivery may reduce postoperative opioid use

No Result

View All Result